furosemide has been researched along with pyrilamine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
Strassburg, CP; Tukey, RH | 1 |
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Caron, G; Ermondi, G | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Cooke, HJ; Kuwahara, A | 1 |
Castro, GA; Russell, DA | 1 |
Bianco, S; Bolla, M; Folco, G; Mezzetti, M; Sala, A; Santinelli, E; Sestini, P | 1 |
1 review(s) available for furosemide and pyrilamine
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
8 other study(ies) available for furosemide and pyrilamine
Article | Year |
---|---|
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Tachykinin-induced anion secretion in guinea pig distal colon: role of neural and inflammatory mediators.
Topics: Animals; Atropine; Chlorides; Colon; Dose-Response Relationship, Drug; Electric Stimulation; Furosemide; Guinea Pigs; Histamine Release; In Vitro Techniques; Male; Pyrilamine; Substance P; Tachykinins; Tetrodotoxin | 1990 |
Immunological regulation of colonic ion transport.
Topics: Animals; Antigens, Helminth; Bradykinin; Colon; Dinoprostone; Electric Conductivity; Evoked Potentials; Furosemide; Guinea Pigs; Histamine Release; Indomethacin; Jejunum; Male; Pyrilamine; Quinacrine; Reference Values; Tetrodotoxin; Trichinella; Trichinellosis | 1989 |
Furosemide attenuates bronchial responsiveness to antigen challenge "in vitro".
Topics: Acetophenones; Acetylcholine; Bronchi; Bronchiectasis; Carcinoma, Bronchogenic; Dicarboxylic Acids; Furosemide; Immunoglobulin E; In Vitro Techniques; Indomethacin; Isometric Contraction; Leukotriene Antagonists; Lung Neoplasms; Membrane Proteins; Muscle, Smooth; Pyrilamine; Receptors, Leukotriene; SRS-A; Tetrazoles | 1995 |